A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Pet Iq, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 42,900 shares of PETQ stock, worth $1.33 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42,900
Previous 6,800 530.88%
Holding current value
$1.33 Million
Previous $150,000 780.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$20.57 - $30.79 $116,673 - $174,640
-5,672 Reduced 56.95%
4,287 $131,000
Q2 2024

Aug 14, 2024

SELL
$15.93 - $22.26 $4.1 Million - $5.72 Million
-257,120 Reduced 96.27%
9,959 $219,000
Q1 2024

May 15, 2024

BUY
$15.55 - $19.42 $3.99 Million - $4.99 Million
256,802 Added 2498.8%
267,079 $4.88 Million
Q4 2023

Feb 14, 2024

SELL
$17.18 - $22.38 $2.58 Million - $3.36 Million
-150,243 Reduced 93.6%
10,277 $202,000
Q3 2023

Nov 14, 2023

BUY
$15.0 - $20.71 $786,330 - $1.09 Million
52,422 Added 48.49%
160,520 $3.16 Million
Q2 2023

Aug 14, 2023

SELL
$10.84 - $15.43 $42,752 - $60,855
-3,944 Reduced 3.52%
108,098 $1.64 Million
Q1 2023

May 15, 2023

SELL
$9.32 - $12.58 $830,775 - $1.12 Million
-89,139 Reduced 44.31%
112,042 $1.28 Million
Q4 2022

Feb 14, 2023

SELL
$6.82 - $12.07 $2.48 Million - $4.4 Million
-364,180 Reduced 64.42%
201,181 $1.85 Million
Q3 2022

Nov 14, 2022

BUY
$6.9 - $18.16 $2.88 Million - $7.58 Million
417,264 Added 281.75%
565,361 $3.9 Million
Q2 2022

Aug 15, 2022

SELL
$14.09 - $25.12 $749,912 - $1.34 Million
-53,223 Reduced 26.44%
148,097 $2.49 Million
Q1 2022

May 16, 2022

BUY
$17.92 - $24.4 $1.8 Million - $2.45 Million
100,553 Added 99.79%
201,320 $4.91 Million
Q4 2021

Feb 14, 2022

BUY
$19.97 - $25.91 $1.07 Million - $1.38 Million
53,393 Added 112.71%
100,767 $2.29 Million
Q3 2021

Nov 15, 2021

SELL
$23.99 - $38.59 $2.96 Million - $4.77 Million
-123,592 Reduced 72.29%
47,374 $1.18 Million
Q2 2021

Aug 16, 2021

BUY
$34.94 - $45.35 $1.06 Million - $1.37 Million
30,274 Added 21.52%
170,966 $6.6 Million
Q1 2021

May 17, 2021

BUY
$32.6 - $37.82 $2.61 Million - $3.03 Million
80,037 Added 131.95%
140,692 $4.96 Million
Q4 2020

Feb 16, 2021

SELL
$24.99 - $38.45 $2.48 Million - $3.82 Million
-99,404 Reduced 62.1%
60,655 $2.33 Million
Q3 2020

Nov 16, 2020

BUY
$29.04 - $37.49 $3.22 Million - $4.16 Million
111,023 Added 226.41%
160,059 $5.27 Million
Q2 2020

Aug 14, 2020

SELL
$20.16 - $34.84 $370,339 - $640,010
-18,370 Reduced 27.25%
49,036 $1.71 Million
Q1 2020

May 15, 2020

SELL
$16.59 - $34.94 $674,400 - $1.42 Million
-40,651 Reduced 37.62%
67,406 $1.57 Million
Q4 2019

Feb 14, 2020

SELL
$22.24 - $27.56 $3.95 Million - $4.9 Million
-177,654 Reduced 62.18%
108,057 $2.71 Million
Q3 2019

Nov 14, 2019

BUY
$25.56 - $36.1 $7.3 Million - $10.3 Million
285,711 New
285,711 $7.79 Million

Others Institutions Holding PETQ

About PetIQ, Inc.


  • Ticker PETQ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,312,800
  • Market Cap $908M
  • Description
  • PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medicat...
More about PETQ
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.